Filana Therapeutics, Inc. (FLNA)
1.955
-0.04
(-1.76%)
USD |
NASDAQ |
Mar 16, 16:00
1.97
+0.02
(+0.77%)
After-Hours: 20:00
Filana Therapeutics Market Cap : 94.44M for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| cbdMD, Inc. | 7.542M |
| BioMarin Pharmaceutical, Inc. | 11.05B |
| Amicus Therapeutics, Inc. | 4.512B |
| NovaBay Pharmaceuticals, Inc. | 38.40M |
| Spero Therapeutics, Inc. | 145.64M |
Market Cap Related Metrics
| PEG Ratio | -0.0345 |
| Price to Book Value | 1.269 |
| Price | 1.955 |
| Earnings Yield | -96.35% |
| PEGY Ratio | -0.0345 |